Aurisco Pharmaceutical Co Ltd (605116) — Cash Flow Reinvestment Rate
Aurisco Pharmaceutical Co Ltd (605116) has a Cash Flow Reinvestment Rate of 3.81x as of December 2024, reinvesting CN¥1.27 Billion (capex CN¥540.28 Million plus investments CN¥-726.77 Million) from operating cash flow of CN¥332.41 Million. See Aurisco Pharmaceutical Co Ltd (605116) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Aurisco Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Aurisco Pharmaceutical Co Ltd across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Aurisco Pharmaceutical Co Ltd.
Annual Cash Flow Reinvestment Rate for Aurisco Pharmaceutical Co Ltd (2017–2024)
Year-by-year capital reinvestment analysis for Aurisco Pharmaceutical Co Ltd. See financial flexibility index of Aurisco Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.81x | CN¥1.27 Billion | CN¥332.41 Million | CN¥540.28 Million | ▲ +119.1% |
| 2023 | 1.74x | CN¥670.75 Million | CN¥385.61 Million | CN¥305.48 Million | ▼ -38.8% |
| 2022 | 2.84x | CN¥473.01 Million | CN¥166.41 Million | CN¥216.23 Million | ▲ +11.7% |
| 2021 | 2.54x | CN¥512.96 Million | CN¥201.57 Million | CN¥250.61 Million | ▲ +72.8% |
| 2020 | 1.47x | CN¥315.81 Million | CN¥214.48 Million | CN¥158.80 Million | ▲ +71.4% |
| 2019 | 0.86x | CN¥154.57 Million | CN¥179.90 Million | CN¥72.47 Million | ▲ +0.2% |
| 2018 | 0.86x | CN¥94.14 Million | CN¥109.77 Million | CN¥94.14 Million | ▼ -5.1% |
| 2017 | 0.90x | CN¥106.60 Million | CN¥117.91 Million | CN¥106.60 Million | — |